GlassScriptPhysician profile
Rachel A Binda
NPI 1629634860
$3,445.84
in general payments reported to CMS, 2019-2025
9 companies · $2,789 in 2025
The $2,789 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $111 · 2023: $177 · 2024: $114 · 2025: $2,789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,546 · Food and Beverage: $1,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,546.28 |
| Food and Beverage | $1,534.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,546.19 | 2025 | General - Therapies, Accolade Sr |
| Abbott Laboratories | $227.77 | 2023-2025 | Ensite Precision, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $208.42 | 2021-2024 | Cobalt Dr Mri Surescan, Micra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.51 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.13 | 2024-2025 | Lifevest |
| Abiomed | $88.33 | 2025 | |
| Alnylam Pharmaceuticals INC. | $22.86 | 2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $20.09 | 2022 | |
| Cardiovascular Systems INC. | $14.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Binda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.